BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminating PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
Gabelli To Host 4th Annual PFAS Symposium
Gabelli Funds released the agenda for its 4th Annual PFAS Symposium, taking place Thursday, September 24, 2026, in Midtown Manhattan, with AECOM among the featured presenters.
AECOM's Dr. Rosa Gwinn, Global PFAS Technical Lead, is slotted for the 9:30 AM session and will participate virtually, alongside speakers from Arq, Minerals Technologies, Veolia, BioLargo, Birchtech, and private remediation firms.
The release is authored by Gabelli Funds, a subsidiary of GAMCO Investors, and contains no new financial or operational disclosure from AECOM itself — it is an investor-conference appearance only.